SPARK THERAPEUTICS, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows, 12 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-02-04: Reporting owner Mehra Anand; Form 4; Security Series B Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-02-04: Reporting owner Mehra Anand; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
- 2015-02-04: Reporting owner SIGAL ELLIOT; Form 4; Security Series B Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-02-04: Reporting owner SIGAL ELLIOT; Form 4; Security Series B Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-02-04 | Mehra Anand Director | 4 | Series B Preferred Stock Derivative · Indirect · See footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,222 1,893,576 owned after | $0.00 | 2015-02-06 | |
| 2015-02-04 | Mehra Anand Director | 4 | Series B Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −1,893,576 0 owned after | $0.00 | 2015-02-06 | |
| 2015-02-04 | SIGAL ELLIOT Director | 4 | Series B Preferred Stock Derivative · Indirect · See footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +503 31,559 owned after | $0.00 | 2015-02-06 | |
| 2015-02-04 | SIGAL ELLIOT Director | 4 | Series B Preferred Stock Derivative · Indirect · See footnote | C Conversion of derivative security | −31,559 0 owned after | $0.00 | 2015-02-06 | |
| 2015-02-04 | Children's Hospital of Philadelphia Foundation 10% Owner | 4 | Series A Preferred Stock Derivative · Direct | C Conversion of derivative security | −1,000,000 0 owned after | $0.00 | 2015-02-05 | |
| 2015-02-04 | Children's Hospital of Philadelphia Foundation 10% Owner | 4 | Series B Preferred Stock Derivative · Direct | C Conversion of derivative security | −2,795,031 0 owned after | $0.00 | 2015-02-05 | |
| 2015-02-04 | Children's Hospital of Philadelphia Foundation 10% Owner | 4 | Accrued Preferred Stock Dividends Derivative · Direct | C Conversion of derivative security | −61,552 0 owned after | $0.00 | 2015-02-05 | |
| 2015-01-29 holding as of filing | Mehra Anand | AKKARAJU SRINIVAS | POWELL MICHAEL | Sofinnova Venture Partners VIII, L.P. | HEALY JAMES | Sofinnova Management VIII, L.L.C. Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Series B Convertible Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2015-01-29 | ||
| 2015-01-29 holding as of filing | SIGAL ELLIOT Director | 3 | Series B Preferred Stock Derivative · Indirect · (m) | Holding | no price filed | 2015-01-29 | ||
| 2015-01-29 holding as of filing | Children's Hospital of Philadelphia Foundation 10% Owner | 3 | Series A Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2015-01-29 | ||
| 2015-01-29 holding as of filing | Children's Hospital of Philadelphia Foundation 10% Owner | 3 | Series B Preferred Stock Derivative · Direct · (m) | Holding | no price filed | 2015-01-29 | ||
| 2015-01-29 holding as of filing | Children's Hospital of Philadelphia Foundation 10% Owner | 3 | Accrued Preferred Stock Dividends Derivative · Direct · (m) | Holding | no price filed | 2015-01-29 |